after one above, and plenty at $CORT (-3,5%) .
Canaccord has left the rating for Corcept (NASDAQ: CORT) to 'buy'. The price target is $110.00 after a previous $100.00.
Prior to this rating, 4 analysts have rated Corcept with a buy rating and 1 with a hold rating. There was 1 Sell recommendation.
Analyst consensus estimates and price targets for Corcept can be found at hier. Further news on Corcept can be found hier.
Corcept's share price ended the official trading session at a closing price of $33.82. The stock's performance was minus -6.63% in the last month and minus -26.07% in the last 12 months.
According to Investing Pro the Fair Value of Corcept is $42.58. This corresponds to a potential return of 2.40%. InvestingPro rates the uncertainty regarding the fair value of Corcept as "medium".
